MultiGEN Diagnostics (Clinical Laboratory Assets) Overview

  • Status
  • Private
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $4.3M
Latest Deal Amount

MultiGEN Diagnostics (Clinical Laboratory Assets) General Information


Developer of multiplexed assays based on a novel modification of the 'Gold Standard' Sanger sequencing method. The company provide accurate and comprehensive bio-informatics for molecular diagnostics, drug development and personalized medicine.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Primary Office
  • 11575 Sorrento Valley Road
  • Suite 206
  • San Diego, CA 92121
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MultiGEN Diagnostics (Clinical Laboratory Assets) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Merger/Acquisition 08-Feb-2012 $4.3M 00.00 Completed Generating Revenue
To view MultiGEN Diagnostics (Clinical Laboratory Assets)’s complete valuation and funding history, request access »